Total Payments
$3,748
2024 Payments
$1,445
Companies
30
Transactions
165
Medicare Patients
2,576
Medicare Billing
$295,616
Payment Breakdown by Category
Food & Beverage$3,748 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,748 | 165 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,717 | 75 | $0 (2024) |
| Celgene Corporation | $257.80 | 19 | $0 (2024) |
| Janssen Biotech, Inc. | $245.78 | 10 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $164.82 | 8 | $0 (2024) |
| INTERCEPT PHARMACEUTICALS, INC. | $152.34 | 9 | $0 (2023) |
| GENZYME CORPORATION | $150.11 | 1 | $0 (2024) |
| PENTAX of America, Inc. | $143.90 | 1 | $0 (2024) |
| Madrigal Pharmaceuticals | $128.37 | 2 | $0 (2024) |
| PFIZER INC. | $117.07 | 7 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $95.74 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,445 | 50 | ABBVIE INC. ($502.78) |
| 2023 | $1,125 | 47 | AbbVie Inc. ($670.83) |
| 2022 | $355.64 | 18 | ABBVIE INC. ($253.59) |
| 2021 | $251.83 | 17 | AbbVie Inc. ($142.31) |
| 2020 | $109.22 | 8 | Merck Sharp & Dohme Corporation ($39.19) |
| 2019 | $185.30 | 11 | AbbVie, Inc. ($58.65) |
| 2018 | $174.33 | 7 | COVIDIEN LP ($81.94) |
| 2017 | $101.42 | 7 | Intercept Pharmaceuticals, Inc. ($42.68) |
All Payment Transactions
165 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $17.10 | General |
| Category: IMMUNOLOGY | ||||||
| 12/17/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $27.01 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/04/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $6.62 | General |
| Category: IMMUNOLOGY | ||||||
| 11/25/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: IMMUNOLOGY | ||||||
| 11/21/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $29.54 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/20/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $25.64 | General |
| Category: Immunology | ||||||
| 11/20/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $7.23 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $14.33 | General |
| Category: Immunology | ||||||
| 11/08/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Food and Beverage | In-kind items and services | $111.59 | General |
| Category: LIVER DISEASE | ||||||
| 11/06/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $29.22 | General |
| Category: Immunology | ||||||
| 10/31/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $6.19 | General |
| Category: Immunology | ||||||
| 10/29/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $30.36 | General |
| Category: Immunology | ||||||
| 10/28/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $25.12 | General |
| Category: Rare Disease | ||||||
| 10/27/2024 | PENTAX of America, Inc. | INSPIRA (Device), PENTAX Medical, PENTAX Medical | Food and Beverage | Cash or cash equivalent | $143.90 | General |
| Category: Gastroenterology | ||||||
| 10/26/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $150.11 | General |
| Category: Immunology | ||||||
| 10/24/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: IMMUNOLOGY | ||||||
| 10/18/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: LIVER DISEASE | ||||||
| 10/17/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $26.71 | General |
| Category: Immunology | ||||||
| 10/10/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $18.74 | General |
| Category: Immunology | ||||||
| 10/08/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $22.11 | General |
| 10/08/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.91 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/30/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $37.34 | General |
| Category: Immunology | ||||||
| 09/12/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $14.80 | General |
| Category: IMMUNOLOGY | ||||||
| 08/29/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $32.05 | General |
| Category: Immunology | ||||||
| 08/19/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $14.08 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 610 | 655 | $386,400 | $74,240 |
| 2022 | 15 | 708 | 771 | $409,780 | $81,149 |
| 2021 | 12 | 711 | 832 | $309,729 | $78,504 |
| 2020 | 9 | 547 | 637 | $247,274 | $61,724 |
Total Patients
2,576
Total Services
2,895
Medicare Billing
$295,616
Procedure Codes
49
All Medicare Procedures & Services
49 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 148 | 150 | $153,750 | $32,252 | 21.0% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 110 | 114 | $73,530 | $8,406 | 11.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 48 | 58 | $15,660 | $5,847 | 37.3% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 84 | 84 | $73,500 | $5,340 | 7.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 57 | 65 | $12,025 | $4,685 | 39.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 36 | 36 | $8,640 | $3,846 | 44.5% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 16 | 16 | $12,000 | $2,930 | 24.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 22 | 22 | $9,020 | $2,756 | 30.6% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 12 | 12 | $9,000 | $2,273 | 25.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 24 | 30 | $3,600 | $1,946 | 54.1% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 22 | 37 | $3,145 | $1,511 | 48.0% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 16 | 16 | $8,480 | $1,316 | 15.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 15 | 15 | $4,050 | $1,131 | 27.9% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 127 | 128 | $131,200 | $27,432 | 20.9% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 96 | 99 | $63,855 | $8,423 | 13.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 74 | 87 | $23,490 | $8,095 | 34.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 54 | 54 | $22,140 | $6,764 | 30.6% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 91 | 92 | $80,500 | $6,478 | 8.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 64 | 66 | $12,110 | $4,596 | 38.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 45 | 74 | $8,880 | $4,358 | 49.1% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 30 | 30 | $7,200 | $3,379 | 46.9% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 15 | 15 | $11,250 | $2,917 | 25.9% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 17 | 17 | $12,750 | $2,567 | 20.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 32 | 32 | $8,640 | $2,521 | 29.2% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 15 | 15 | $2,250 | $1,256 | 55.8% |
About Nasir Akhtar
Nasir Akhtar is a Gastroenterology healthcare provider based in Doylestown, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/19/2012. The National Provider Identifier (NPI) number assigned to this provider is 1376816504.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Nasir Akhtar has received a total of $3,748 in payments from pharmaceutical and medical device companies, with $1,445 received in 2024. These payments were reported across 165 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($3,748).
As a Medicare-enrolled provider, Akhtar has provided services to 2,576 Medicare beneficiaries, totaling 2,895 services with total Medicare billing of $295,616. Data is available for 4 years (2020–2023), covering 49 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Doylestown, PA
- Active Since 02/19/2012
- Last Updated 07/17/2019
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1376816504
Products in Payments
- RINVOQ (Biological) $700.63
- SKYRIZI (Biological) $452.14
- ZEPOSIA (Drug) $340.53
- MAVYRET (Drug) $223.05
- DUPIXENT (Biological) $172.02
- TREMFYA (Drug) $155.46
- INSPIRA (Device) $143.90
- HUMIRA (Biological) $122.47
- REZDIFFRA (Drug) $111.59
- ENTYVIO (Biological) $108.90
- Mavyret (Drug) $96.36
- OCALIVA (Drug) $96.33
- STELARA (Biological) $90.32
- DIFICID (Drug) $74.79
- BARRX (Device) $53.40
- XELJANZ (Drug) $53.26
- CREON (Drug) $48.40
- INFLECTRA (Biological) $46.86
- OCA (Drug) $42.68
- Humira (Biological) $36.31
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Doylestown
Victor Araya, Md, MD
Gastroenterology — Payments: $157,364
Gastroenterology $157,364
Dr. Mayurathan Kesavan, M.d, M.D
Gastroenterology — Payments: $113,246
Gastroenterology $113,246
Dr. Marion-Anna Protano, M.d, M.D
Gastroenterology — Payments: $46,741
Gastroenterology $46,741
Dr. Hannah Do, M.d, M.D
Gastroenterology — Payments: $11,244
Gastroenterology $11,244
Sandhya Salguti, Md, MD
Gastroenterology — Payments: $7,558
Gastroenterology $7,558
Dr. Robert Hale, M.d, M.D
Gastroenterology — Payments: $6,692
Gastroenterology $6,692